Induced apoptosis by mild hyperthermia occurs via telomerase inhibition on the three human myeloid leukemia cell lines: TF-1, K562, and HL-60

被引:6
作者
Deezagi, Abdolkhaleg [1 ]
Manteghi, Sanaz [1 ]
Khosravani, Pardis [1 ]
Vaseli-Hagh, Neda [1 ]
Soheili, Zahra-Soheila [1 ]
机构
[1] Natl Inst Genet Engn & Biotechnol, Dept Biochem, Tehran, Iran
关键词
Mild hyperthermia; telomerase activity; human leukemic cells; apoptosis; differentiation; HEAT-SHOCK; DIFFERENTIATION; PROLIFERATION; PROTEIN; STRESS; TRANSCRIPTION; CHEMOTHERAPY; ACTIVATION; CARCINOMA; RESPONSES;
D O I
10.1080/10428190903129130
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this research was to understand the effect of hyperthermia on the telomerase activity in human leukemic cell lines (HL-60, K562, and TF-1). The cells were treated by hyperthermia at the range of 41-44 degrees C for 120 min and incubated for 96 h. Then telomerase activity, cell proliferation, and apoptosis were assessed. The results indicated that hyperthermia significantly induced apoptosis on the cells. The cells exhibited pre-apoptotic pattern at 41 and 42 degrees C at 60-120 min and apoptotic pattern at 43 and 44 degrees C over 30 min after hyperthermia. Telomerase activity (that was assayed immediately after hyperthermia) was stable at 41-42 degrees C for 60 min but decreased to 35-40% at 120 min. However, at severe hyperthermia (43-44 degrees C) telomerase activity was decreased in a time-and dose-dependent manner. Following hyperthermia (41-44 degrees C up to 120 min), the cells were incubated for 96 h. In these conditions, the telomerase activity was decreased by about 60-80% in comparison with that untreated control cells.
引用
收藏
页码:1519 / 1527
页数:9
相关论文
共 31 条
[1]  
Aragona M, 2000, INT J ONCOL, V17, P981
[2]   41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases [J].
Atanackovic, D ;
Nierhaus, A ;
Neumeier, M ;
Hossfeld, DK ;
Hegewisch-Becker, S .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) :603-613
[3]   The treatment of malignancy by hyperthermia [J].
Christophi, C ;
Winkworth, A ;
Muralihdaran, V ;
Evans, P .
SURGICAL ONCOLOGY-OXFORD, 1998, 7 (1-2) :83-90
[4]   ARRHENIUS RELATIONSHIPS FROM THE MOLECULE AND CELL TO THE CLINIC [J].
DEWEY, WC .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1994, 10 (04) :457-483
[5]   Effects of hyperthermia and granulocyte-macrophage colony-stimulating factor on the differentiation of human leukemic cell line U937 [J].
Goliaei, B ;
Deizadji, A .
LEUKEMIA RESEARCH, 1998, 22 (08) :705-710
[6]   THE HEAT-CAPACITY OF PROTEINS [J].
GOMEZ, J ;
HILSER, VJ ;
XIE, D ;
FREIRE, E .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1995, 22 (04) :404-412
[7]   TELOMERE REDUCTION IN HUMAN COLORECTAL-CARCINOMA AND WITH AGING [J].
HASTIE, ND ;
DEMPSTER, M ;
DUNLOP, MG ;
THOMPSON, AM ;
GREEN, DK ;
ALLSHIRE, RC .
NATURE, 1990, 346 (6287) :866-868
[8]   Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin [J].
Jaster, R ;
Bittorf, T ;
Klinken, SP ;
Brock, J .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (09) :1181-1185
[9]   The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells [J].
Jing Shen ;
Weijing Zhang ;
Jun Wu ;
Yunfeng Zhu .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2008, 24 (02) :151-159
[10]  
Keith WN, 2004, METH MOLEC MED, V97, P311